2seventy bio, Inc. (TSVT)
May 13, 2025 - TSVT was delisted (reason: acquired by BMY)
5.00
0.00 (0.00%)
Inactive · Last trade price on May 12, 2025

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Treatments for Cancer
100.39M

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
United States
100.39M